Heavy metals are elements that accumulate in biological tissue, resist normal metabolic breakdown, and at sufficient concentrations impair enzyme function, disrupt cellular signalling, and generate oxidative damage across multiple organ systems. The clinically significant ones in most modern environments are lead, mercury, arsenic, cadmium, and aluminium — with nickel, tin, thallium, and antimony appearing in specific occupational and environmental contexts. None of them have any known biological function at the concentrations at which they accumulate. All of them compete with essential minerals for the receptor sites and enzyme binding positions those minerals should occupy.
The reason toxic metal burden is so frequently missed in standard clinical investigation is straightforward: the standard test looks in the wrong place. A serum heavy metals panel measures what is currently circulating in the blood. Metals circulate in blood for a matter of hours to days following an acute exposure before being sequestered into tissue — bone, liver, kidney, brain, adipose tissue, and hair. A serum test will be negative for someone with significant tissue accumulation of mercury or lead because the metal left the bloodstream years ago. It is now in their brain, their bones, or their hair follicle cells.
This is not a limitation unique to functional medicine perspective. The CDC’s own guidance on lead and mercury exposure acknowledges that blood levels only reflect recent acute exposure. For chronic low-level accumulation — the pattern relevant to most people with unexplained neurological symptoms, joint pain, chronic fatigue, and cognitive difficulty — a different testing approach is required.
The Testing Options — What Each One Actually Measures
The OAT as the First Signal
In clinical practice, the Organic Acids Test is frequently where toxic burden first becomes visible — not because it measures metals directly, but because it measures what metals do to cells. The key markers:
Pyroglutamic acid — elevated pyroglutamate is the most sensitive marker of glutathione depletion available on routine testing. Glutathione is the primary cellular defence against heavy metals: it chelates metals, drives their transport into cells for excretion, and protects against the free radical damage that metal accumulation generates. When glutathione is profoundly depleted, pyroglutamate accumulates. A person with significantly elevated pyroglutamate and a history of occupational exposure, amalgam fillings, high fish consumption, or residence in an old building has a plausible clinical picture for metal burden as a contributing cause.
Hippuric acid — produced in the liver as a glycine conjugate of benzoic acid, elevated hippuric acid reflects either high benzoate exposure through diet or impaired liver capacity to process xenobiotic compounds. In people with occupational solvent exposure or significant environmental chemical burden, elevated hippuric acid alongside pyroglutamate elevation creates a consistent toxic exposure pattern.
Krebs cycle disruption markers — heavy metals inhibit several key mitochondrial enzymes, particularly those involved in the citric acid cycle and oxidative phosphorylation. Patterns of Krebs cycle intermediate accumulation on the OAT, in the context of the above markers, suggest mitochondrial impairment from toxic causes rather than simple nutritional deficiency.
Hair Tissue Mineral Analysis — The Underappreciated Clinical Tool
Hair tissue mineral analysis has a complicated reputation. It has been oversold by practitioners who treat its results as direct measurements of body burden without understanding what it is actually measuring. And it has been unfairly dismissed by critics who apply that justified criticism to the test as a whole, ignoring the genuine clinical information it provides when interpreted correctly.
What HTMA measures is the mineral and metal content deposited in the hair shaft as it grows. Hair grows approximately one centimetre per month. A one to two centimetre sample from the nape of the neck — the closest to the scalp, reflecting the most recent growth — captures the mineral and metal excretion pattern of the preceding eight to twelve weeks. It is an excretory tissue sample, not a tissue storage sample. This distinction is critical for correct interpretation.
Hair tissue mineral analysis does not tell you how much mercury is stored in your brain. It tells you how much mercury your body has been excreting through hair over the past eight to twelve weeks. In a person actively mobilising mercury from tissue — through natural detoxification processes or chelation support — HTMA shows elevated mercury excretion. In a person with deeply sequestered mercury who is not currently mobilising it, HTMA may show low mercury despite significant tissue stores.
This limitation is real and must inform interpretation. But it does not eliminate the clinical value of HTMA. It shifts what you are reading from a body burden measurement to a metabolic and excretory pattern — which is itself clinically informative.
The Mineral Displacement Patterns
The most underappreciated aspect of HTMA is not the metal data but the mineral ratios. Toxic metals compete with essential minerals for enzyme binding sites, transport proteins, and cellular uptake pathways. When toxic metals accumulate, they displace the essential minerals that should occupy those positions — and these displacement patterns are visible on HTMA in ways that neither blood chemistry nor urine testing captures as clearly.
Mercury displacing selenium and zinc
Mercury binds selenium with extraordinary affinity — forming mercury selenide complexes that sequester both elements. Low selenium on HTMA in the context of a mercury exposure history may reflect mercury-selenium sequestration rather than dietary selenium deficiency. Zinc displacement by mercury impairs the zinc-dependent enzyme systems including carbonic anhydrase, superoxide dismutase, and DNA repair enzymes.
Lead displacing calcium and zinc
Lead mimics calcium in biological systems — it is taken up by the same transport mechanisms, stored in bone alongside calcium, and mobilised from bone when calcium is mobilised. Low calcium with elevated lead on HTMA, particularly in a context of dairy avoidance or calcium-deficient diet, suggests lead-calcium competition. Lead also displaces zinc from zinc-dependent enzymes, impairing cognitive function through the same enzymatic pathway as mercury.
Cadmium displacing zinc
Cadmium — primarily from cigarette smoke, contaminated soil, and some seafood — competes directly with zinc for intestinal absorption and cellular uptake. Low zinc with elevated cadmium is one of the clearest displacement patterns. Cadmium also accumulates in the kidney tubules, impairing the renal handling of calcium, phosphate, and amino acids over decades of exposure.
Aluminium displacing magnesium
Aluminium competes with magnesium for enzyme binding sites, particularly in ATP-dependent reactions. Given how many metabolic processes are magnesium-dependent, aluminium-magnesium competition is metabolically significant. Aluminium exposure — from cookware, antacids, some vaccines, and environmental sources — is pervasive and largely unmeasured in clinical practice.
These displacement patterns matter because they mean that nutrient deficiency findings on blood chemistry may not be simply dietary deficiencies responding to supplementation. A person who repeatedly fails to normalise zinc status despite adequate supplementation may have ongoing zinc displacement by cadmium or mercury that supplementation alone cannot address. Identifying the displacement is the prerequisite for addressing it effectively.
The Case for HTMA as a Clinical Entry Point
Beyond what it measures, HTMA has practical clinical advantages that the other testing options do not share — and these matter in real-world practice more than a theoretical ranking of test accuracy.
Children who cannot or will not do blood draws
Venepuncture in children requires significant co-operation and causes distress. Hair collection requires scissors and thirty seconds. For assessing mineral status, toxic metal exposure, and metabolic mineral patterns in a child — the clinical questions that most frequently arise in paediatric functional medicine contexts — HTMA provides an informative starting point with zero procedural barrier.
People who find stool testing genuinely unmanageable
The GI-MAP is the most informative gut test available. It is also a stool collection. A proportion of people find this genuinely difficult — practically, psychologically, or due to bowel habit irregularity that makes reliable sample collection challenging. For these people, a hair sample collected at any time of day, in any location, without timing constraints or collection kits, is the accessible option that produces results rather than the abandoned test kit that produces nothing.
People who cannot manage the DUTCH collection protocol
The DUTCH Plus requires four urine collections at specific times across the day, plus four saliva samples on waking. For people with cognitive difficulties, organisational challenges, shift work patterns, or significant stress that makes precise timing difficult, adherence to the DUTCH protocol is genuinely challenging. A teaspoon of hair from the back of the head requires none of that.
As a lower-cost entry point generating actionable information
HTMA typically costs a fraction of the five-test TDG programme. For clients who are uncertain whether functional testing is for them, who are navigating financial constraints, or who need a lower-stakes first step before committing to a more comprehensive investigation, HTMA provides genuine clinical information at an accessible price point. The mineral ratios, the toxic metal excretion pattern, and the metabolic picture together generate hypotheses that inform whether more comprehensive testing is warranted and which tests are most likely to be highest yield.
The Limitations — What HTMA Cannot Tell You
Responsible HTMA interpretation requires clarity about what the test does not provide.
External contamination is a genuine variable. Hair exposed to shampoos, hair dyes, bleaching agents, and environmental particulates carries those chemicals into the analysis. Collection from the nape of the neck with unwashed, uncoloured hair minimises but does not eliminate this. Any HTMA result that shows an unusual metal pattern should be cross-referenced with known exposure history before being acted on.
Low metal excretion on HTMA does not rule out body burden. A person with deeply sequestered metals who is not actively mobilising them will show low metal on HTMA — because HTMA measures excretion, not storage. A person with poor detoxification capacity may have high body burden and low excretion simultaneously. The OAT pyroglutamate marker — the glutathione depletion signal — is often more sensitive to high body burden than HTMA in people with compromised detoxification.
HTMA also cannot replace the GI-MAP for gut health, the DUTCH for hormonal patterns, or blood chemistry for metabolic markers. It occupies a specific position in the testing hierarchy — informative for mineral ratios and excretion patterns, incomplete for everything else.
When Provoked Urine Testing Is Warranted
Provoked urine metal testing — administering a chelating agent and collecting urine over the following hours — provides the most direct available measure of tissue metal burden. It is warranted when the clinical picture strongly suggests significant accumulation: specific occupational history (printing, dentistry, welding, painting), radiographic evidence of bone lead accumulation, neurological symptoms consistent with chronic metal toxicity, or OAT findings showing severe glutathione depletion alongside known exposure history.
It is not a first-line screening test. The chelating agent mobilises metals from tissue storage into circulation and urine — producing a temporarily high circulating metal load that can worsen neurological and other symptoms in the short term. This effect is manageable and temporary, but it is a clinical event that requires appropriate support: adequate glutathione precursors to support the increased excretion demand, adequate hydration, and monitoring of symptoms during and after the collection period.
This is why the investigation sequence matters. OAT and HTMA as initial orientation, clinical history and symptom pattern to assess probability, provoked urine testing when the evidence is sufficiently compelling. Not provoked urine testing as a first step in everyone who suspects they might have metal issues from reading about it online.
Start with clinical history. Occupational exposure. Old amalgam fillings. High fish consumption. Residence in pre-1970s buildings (lead paint, lead pipes). Geographic location (mining areas, industrial proximity). This history determines prior probability before any test is ordered.
OAT as functional signal. Pyroglutamate, hippuric acid, and Krebs cycle markers establish whether the cells are under oxidative assault consistent with toxic burden. This is often where metal toxicity first becomes clinically visible.
HTMA for mineral patterns and excretion. The mineral displacement ratios and toxic metal excretion pattern add another layer. Particularly valuable where OAT suggests burden but the metal has not been identified, or where HTMA is the most accessible option given patient circumstances.
Blood metals for acute or recent exposure. If the exposure is recent (within weeks), blood testing is appropriate. For historical accumulation, it is not the right tool.
Provoked urine when tissue burden is clinically indicated. Under supervision, with appropriate support, when the prior evidence from history and functional testing makes tissue accumulation likely.
We live in an environment of unprecedented chemical complexity — more synthetic compounds, more heavy metal sources, more persistent organic pollutants than any previous generation has encountered. The body’s detoxification systems were not designed for this load, and the clinical consequences — chronic fatigue, cognitive difficulty, joint pain, mood instability, immune dysregulation — are often attributed to everything except their environmental cause, because standard investigation never looks for it. Testing for toxic burden is not conspiracy thinking. It is appropriate clinical investigation of a genuinely prevalent and genuinely under-investigated category of health disruption.
The question is not whether to test, but which test, in what context, for which clinical question. And the answer, as always, depends on the individual.